18595-15-8

Basic information

• Product Name: METHYL 3-AMINO-5-METHYLBENZOATE
• Synonyms: METHYL 3-AMINO-5-METHYLBENZOATE;3-Amino-5-methylbenzoic acid methyl ester;Methyl 5-amino-3-iodobenzoate
• CAS NO: 18595-15-8
• Molecular Formula: C₉H₁₁NO₂
• Molecular Weight: 165.19
• Mol File: 18595-15-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 303.1°C at 760 mmHg
• Flash Point: 158.1°C
• Appearance: /
• Density: 1.132g/cm³
• Vapor Pressure: 0.000949mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: METHYL 3-AMINO-5-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-AMINO-5-METHYLBENZOATE(18595-15-8)
• EPA Substance Registry System: METHYL 3-AMINO-5-METHYLBENZOATE(18595-15-8)

Safety Data

• Hazardous Substances Data: 18595-15-8(Hazardous Substances Data)

Usage

General Description

Methyl 3-amino-5-methylbenzoate is a compound with the chemical formula C9H11NO2. It is derived from benzoic acid and contains an amino group and a methyl group. This chemical is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs. It is also used in the production of dyes and pigments. Methyl 3-amino-5-methylbenzoate is known for its mild anesthetic properties and is used in topical pain relief formulations. It is important to handle this chemical with care as it may be harmful if ingested or inhaled and can cause irritation to the skin and eyes.

InChI:InChI=1/C9H11NO2/c1-6-3-7(9(11)12-2)5-8(10)4-6/h3-5H,10H2,1-2H3

Upstream product

• 58530-13-5 3-bromo-5-methyl-benzoic acid 

Relevant articles and documents

FUSED BICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE

Fused bicyclic compounds and uses thereof in medicine. In particular, provided are fused bicyclic compounds used as ASK1 active regulator and and use of the compounds in the manufacture of a drug for treating a disease regulated by ASK1. Further provided are a pharmaceutical composition and a method of treating a disease regulated by ASK1 comprising administering the compounds or pharmaceutical composition thereof.

1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS

This invention relates to pharmaceutically acceptable salts of compounds of formula (I) wherein: W is N or N+-O-; R2 is an optionally substituted C1 to C18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms. R3 is -(CR11R12)m-X-(CR13R14)p-R9; m is 0, 1, 2, 3 or 4; p is 0, 1 or 2; X is a bond, -CR15=CR16-, -C≡C-, C(O)NH, NHC(O), C(O)NMe, NMeC(O), C(O)O, NHC(O)NH, NHC(O)O, OC(O)NH, NH, O, CO, SO2, SO2NH, C(O)NHNH, R9 is H ; C1 to C6 alkyl ; or phenyl, naphthyl, pyridyl, benzimidazolyl, indazolyl, quinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, indolinyl, isoindolinyl, indolyl, isoindolyl or 2-pyridonyl substituted with -L-Q. R4 is an optionally substituted C1 to C18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms ; and Such salts are useful, for example, for the treatment of gastrin related disorders.